1. Home
  2. Company search

Company search

KOBE Life Science Cluster Company List

Business Expansion
on Kobe's Port Island



as of November 30, 2022

Companies are divided into each categories by their major business field on Kobe Port Island. In the case they have other business fields, it is shown in the miner field.» List of KBIC companies(PDF)

≫ StartupsStartups Company List

Search by Company name or Keyword

Chiral Design Laboratory

Major field:Chemical Synthesis

Miner field:Contract Research

Development of manufacturing technologies for fine chemicals including pharmaceutical intermediates

chromocenter Inc.

Major field:Drug Discovery

Miner field:Regenerative Medicine

R&D of stable and high-efficient method for antibody manufacturing required for antibody drugs


・Our technical strength resides on ability to introduce large set of genes and their regulatory regions into practically any cells. Those genes are introduced to host in a form of artificial chromosomes, which enable us to develop stable cell lines compared with ones using plasmid.
・We are providing simple chromosome analysis (Q-band, G-band), FISH, multi color FISH, and high resolution gene mapping services.

Product / Service / PR

    ・Very high yield, stable cell lines for protein/antibody production can be made using our proprietary HAC/MAC vector technology. chromocenter is your service partner that will help speed your large molecule drug development to clinic. ・We are providing simple chromosome analysis (Q-band, G-band), FISH, multi color FISH, and high resolution gene mapping services.
Address: HI-DEC 4F, 6-7-4, Minatoshima Minami-machi, Chuou-ku, Kobe, 650-0047, JAPAN  (Contact Person Hironori Okamoto)
TEL: +81-78-599-9383
Web site: http://www.chromocenter.com E-mail: okamoto@chromocenter.com


Major field:Diagnostic Agent and Device

Miner field:Genomics

Miner field:Outsourcing Business for Hospital

R&D, production and sale of biochips


The biochip technology of MYTEC can detect the substance of a very very small quantity molecular level in a short time. It was the first in the world to success is effective to adsorb specifically protein biochip surface "quantum crystal," "peroxide meso silver crystal" (3-dimensional self-assembled crystal) produced.
Simple, rapid, epigenetic analysis Proteo ® chip is the "new biochip".

Product / Service / PR

    Products: Proteo ® chip
    ・Detection from Stage 0 (very early diagnosis)
    ・Measurement time is the world's fastest (Detected within 10 minutes)
    ・Identification of cancer types
    Identification of cancer types and screening of cancer presence or absence can be checked at the same time from the blood of 1μl slightly.
Address: HI-DEC Kobe 101, 6-7-4 Minatojimaminamimachi,Kobe Chuo-ku, Hyogo 650-0047 JAPAN  (Contact Person Hasegawa Yuki)
TEL: +81-79-228-2806
Web site: http://www.sers-mytech.com/index.php E-mail: mytech@maia.eonet.ne.jp

Oncolys BioPharma Inc.

Major field:Drug Discovery

Miner field:Production of Drugs and Quasi Drugs

Miner field:Diagnostic Agent and Device

R&D of medicine


Unique drug discovery and development standing on virology.
We do our business activities of pharmaceutical and diagnostic businesses together under the concept of "drug discovery and development standing on virology".
In pharmaceutical business, we will develop safe, effective and novel drug targeting "cancer and serious infectious diseases" that can be a new option of therapy for such intractable diseases. In diagnostic business, we will provide new inspection services using genetic modification technology for virus that is our platform technology. We will establish multiple earning structures based on the achievement by the activities above, and accelerate the development of current new drug candidates under more stable management environment. In addition, we will actively seek or obtain seeds for new drugs to continue and expand our business for the future.

Product / Service / PR

    TelomeScan is a gene-modified virus for detecting cancer cell. The insertion into the virus of a green fluorescent protein (GFP) gene from jellyfish causes cancer cells to emit green fluorescent light as the virus replicates within them, enabling sensitive detection of circulating tumor cells (CTC) which detach from the tumor and circulate within the blood. We focus on especially the detection of CTCs in lung cancer that was difficult to efficiently detect using the conventional technologies and the detection of CTCs on prostate cancer and breast cancer. In these areas, increase in the number of patients is predicted. Oncolys BioPharma provides services not only reporting the number of CTCs in blood but also analyzing the grade of malignancy (T-CAS: TelomeScan CTC Analysis System), and it is expected that such services allow prediction of prognosis and the selection of appropriate treatments of cancer patients. It is further expected that Telome Scan realizes gene analysis services using CTCs (T-GEN: TelomeScan Genotyping System) and facilitates the option to select anti-cancer drugs suitable for cancer patients without conducting risky tissue biopsy for cancers.
Address: 4-1-28 Toranomon, Minato-ku, Tokyo, 105-0001, JAPAN  (Contact Person Corporate Planning Department)
TEL: +81-3-5472-1578 FAX: +81-3-5472-1488
Web site: https://www.oncolys.com E-mail: oncolys_information@oncolys.com

Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

Major field:Assisting Businesses, Rental Laboratories and Offices

Operating Kobe Medical Device Development Center, Kobe Healthcare Industry Development center, etc.


Major field:Chemical Synthesis

Miner field:Contract Research

Miner field:Production of Drugs and Quasi Drugs

R&D of pharmaceutical intermediates